Ad
related to: ATNM
Search results
Actinium (ATNM) Stock Jumps 8.6%: Will It Continue to Soar?
Zacks via Yahoo Finance· 2 years agoActinium (ATNM) witnessed a jump in share price last session on above-average trading volume. The...
Actinium Pharma Cratered 37% Over Two Days — Here's Why, According To CEO Sandesh Seth
Investor's Business Daily· 1 year agoActinium Pharmaceuticals has lofty ambitions to change the landscape of leukemia treatment in as...
With Upcoming Pivotal Data, Analyst Sees 145% Upside In Actinium
Benzinga via Yahoo Finance· 2 years agoCantor Fitzgerald initiated coverage on Actinium Pharmaceuticals Inc (NYSE: ATNM) with an Overweight...
Actinium Shares Are Trading Higher After Positive Data From Acute Myeloid Leukemia Trial
Benzinga via Yahoo Finance· 2 years agoActinium Pharmaceuticals Inc (NASDAQ: ATNM) announced positive topline results from the pivotal...
Has Alkermes (ALKS) Outpaced Other Medical Stocks This Year?
Zacks via Yahoo Finance· 2 years agoInvestors interested in Medical stocks should always be looking to find the best-performing...
Actinium: Q1 Earnings Snapshot
AP Finance via Yahoo Finance· 12 months agoNEW YORK (AP) — NEW YORK (AP) — Actinium Pharmaceuticals Inc. (ATNM) on Monday reported a loss of $11 million in its first quarter. The New York-based company said it had a loss of 43 cents ...
High-Risk, High-Reward: Little-Known Biotech Stock ATNM Could Soar on Breakthrough Cancer Treatment
InvestorPlace via Yahoo Finance· 2 months agoFew stock sectors offer soar-or-sink possibilities like biotechnology stocks do. If you’re in the market for an intriguing biotech pick and can manage high risk, take a look at Actinium Pharmaceuticals ...
7 Biotech Penny Stocks on the Verge of Clinical Trial Victory
InvestorPlace via Yahoo Finance· 2 months agoWhile targeting the therapeutic side of the healthcare sector can be quite lucrative, nothing...
Biotech on a Budget: 7 Stocks Under $10 With Huge Potential
InvestorPlace via Yahoo Finance· 3 weeks agoThe broader medical therapeutic sector is already volatile so it stands to reason in some sense to...
CV Sciences, Inc. (CVSI) Reports Q2 Loss, Lags Revenue Estimates
Zacks via Yahoo Finance· 2 years agoCV Sciences, Inc. (CVSI) delivered earnings and revenue surprises of 0% and 15.21%, respectively,...